Paula Colmenero
TransNAT Programme Manager
In my role as Programme Manager I provide operational leadership for TransNAT, an international research consortium aiming to advance Nucleic-Acid Therapeutics delivery platforms. Here I work closely with academic and industry partners to drive projects forward and ensure targets are met.
Prior to this role I've gained 8 years of experience as Scientific Project Manager supporting translational medical research across the University of Oxford.
My background is in immunology, with a PhD from the Karolinska Institute and a postdoc at Stanford University. I also worked in the biotech sector, before moving to Oxford to engage in translational research.
Recent publications
Inflammatory disease microbiomes share a functional pathogenicity predicted by C-reactive protein.
Journal article
Britton GJ. et al, (2025), bioRxiv
Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes.
Journal article
Thompson KN. et al, (2023), Sci Transl Med, 15
C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
Journal article
Hornum L. et al, (2017), PLoS One, 12
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis.
Journal article
Söderström K. et al, (2010), Proc Natl Acad Sci U S A, 107, 13028 - 13033
Natural killer cells trigger differentiation of monocytes into dendritic cells.
Journal article
Zhang AL. et al, (2007), Blood, 110, 2484 - 2493